Acesso livre
Acesso livre

Saúde Pública/Medicina Humanitária

Compreendendo a transição da COVID-19 para endemicidade.

1 Out, 2021 | 21:59h

Transition to endemicity: Understanding COVID-19 – Cell

Conteúdos relacionados:

COVID will likely shift from pandemic to endemic — but what does that mean?

Perspective | How Endemic COVID Becomes a Manageable Risk – “Businesses and schools must adapt, because the dual threat from the coronavirus and the flu will be too severe”.

Estudo randomizado com mais de 30.000 pacientes mostrou que a vacina da AstraZeneca é segura e teve 74% de eficácia contra infecção sintomática por SARS-CoV-2.

1 Out, 2021 | 20:27h

Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine – New England Journal of Medicine

 

Comentários no Twitter

 

[Comunicado de imprensa – Ainda não publicado] Candidata da Clover a vacina contra COVID-19 demonstra 79% de eficácia contra a variante Delta.

1 Out, 2021 | 20:25h

Clover’s COVID-19 Vaccine Candidate Demonstrates 79% Efficacy Against Delta in Global Phase 2/3 SPECTRA Trial Dominated by Variants of Concern and Interest – Clover Biopharmaceutical

Comentário: New Chinese vaccine could bolster global arsenal – Science

Recapitulando a pandemia: lições que aprendemos.

1 Out, 2021 | 20:24h

A pandemic recap: lessons we have learned – World Journal of Emergency Surgery

Mais de um 1/3 dos pacientes com COVID-19 são posteriormente diagnosticados com pelo menos um sintoma de “long COVID”.

1 Out, 2021 | 20:22h

Comunicado de imprensa: Over a third of COVID-19 patients diagnosed with at least one long-COVID symptom – University of Oxford

Estudo original: Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19 – PLOS Medicine

Comentários:

Two studies tie long COVID-19 to severe initial illness – CIDRAP

Covid: 37% of people have symptoms six months after infection – The Guardian

Long Covid is a bigger problem than we thought – CNN

Expert reaction to study looking at incidence and co-occurrence of long COVID symptoms following COVID-19 infection and also after influenza – Science Media Centre

Dia Mundial do Coração 2021 | COVID-19, saúde digital e combate à doença cardiovascular.

1 Out, 2021 | 20:17h

World Heart Day 2021: COVID-19, digital health, and tackling cardiovascular disease – The Lancet

 

Comentário no Twitter

 

Otimização do uso de antibióticos em humanos – Revisão das evidências atuais e consenso interdisciplinar sobre as prioridades para a pesquisa.

1 Out, 2021 | 20:06h

Optimising antimicrobial use in humans – review of current evidence and an interdisciplinary consensus on key priorities for research – The Lancet Regional Health – Europe

Revisão sistemática | Caracterização da “long COVID”.

1 Out, 2021 | 19:37h

Characterising long COVID: a living systematic review – BMJ Global Health

Conteúdos relacionados:

Long Covid – The illness narratives.

New guidelines to help doctors manage long COVID patients published.

M-A: More than 50 long-term effects of COVID-19. (vários artigos sobre o tema)

 

Comentário no Twitter

 

Estudo CDC | Taxas de efeitos colaterais de uma terceira dose de vacina contra Covid-19 parecem similares àquelas após a segunda dose.

1 Out, 2021 | 19:35h

Side effect rates from a third Covid-19 vaccine dose similar to those after second shot, early data indicate – STAT

Estudo original: Safety Monitoring of an Additional Dose of COVID-19 Vaccine — United States, August 12–September 19, 2021 – CDC Morbidity and Mortality Weekly Report

Nunca desperdice uma pandemia: estratégias para aumentar as diretrizes avançadas de final de vida agora.

1 Out, 2021 | 19:32h

Never Waste a Pandemic: Strategies to Increase Advance Care Planning Now – Mayo Clinic Proceedings

Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.